English

• 1. [1]

     Kaur, S.; Keyang, X.; Ola, S.; Randall, D.; Montserrat, C.-T. Bioanalysis 2013, 5 (2), 201.Kaur, S.; Keyang, X.; Ola, S.; Randall, D.; Montserrat, C.-T. Bioanalysis 2013, 5 (2), 201.

  2. [2]

     Sievers, E. L. Blood Cells Mol. Dis. 2003, 31 (1), 7.Sievers, E. L. Blood Cells Mol. Dis. 2003, 31 (1), 7.

  3. [3]

     Strebhardt, K.; Ullrich, A. Nat. Rev. Cancer 2008, 8 (6), 473.Strebhardt, K.; Ullrich, A. Nat. Rev. Cancer 2008, 8 (6), 473.

  4. [4]

     赵晨曦, 胡卓伟, 崔冰. 药学学报, 2017, 52 (6), 837.

  5. [5]

     Nie, S.; Wang, Z.; Moscoso-Castro, M.; D'Souza, P.; Lei, C.; Xu, J.; Gu, J. Antib. Ther. 2020,3 (1), 18.Nie, S.; Wang, Z.; Moscoso-Castro, M.; D'Souza, P.; Lei, C.; Xu, J.; Gu, J. Antib. Ther. 2020,3 (1), 18.

  6. [6]

     Williams, P.; Handler, L. Am. J. Manag. Care 2000, 6 (18 Suppl.), S975.Williams, P.; Handler, L. Am. J. Manag. Care 2000, 6 (18 Suppl.), S975.

  7. [7]

     Sievers, L.; Appelbaum, R.; Spielberger, R.; Forman, S.; Flowers, D.; Smith, F.; Shannon-Dorcy, K. Blood 1999, 93 (11), 3678.Sievers, L.; Appelbaum, R.; Spielberger, R.; Forman, S.; Flowers, D.; Smith, F.; Shannon-Dorcy, K. Blood 1999, 93 (11), 3678.

  8. [8]

     Dan, N.; Setua, S.; Kashyap, V. K.; Khan, S.; Jaggi, M.; Yallapu, M. M.; Chauhan, S. C. Pharmaceuticals (Basel) 2018, 11 (2), 32.Dan, N.; Setua, S.; Kashyap, V. K.; Khan, S.; Jaggi, M.; Yallapu, M. M.; Chauhan, S. C. Pharmaceuticals (Basel) 2018, 11 (2), 32.

  9. [9]

     Hamann, P. R. In Accounts in Drug Discovery:Case Studies in Medicinal Chemistry; Barrish, J. C., Carter, P. H., Cheng, P. T. W., Zahler, R., Eds.; The Royal Society of Chemistry:Cambridge, UK, 2011; pp. 103-119.Hamann, P. R. In Accounts in Drug Discovery:Case Studies in Medicinal Chemistry; Barrish, J. C., Carter, P. H., Cheng, P. T. W., Zahler, R., Eds.; The Royal Society of Chemistry:Cambridge, UK, 2011; pp. 103-119.

  10. [10]

      Kostova, V.; Désos, P.; Starck, J. B.; Kotschy, A. Pharmaceuticals (Basel) 2021,14 (5), 442.Kostova, V.; Désos, P.; Starck, J. B.; Kotschy, A. Pharmaceuticals (Basel) 2021,14 (5), 442.

  11. [11]

      Godwin, D.; Gale, P.; Walter, B. Leukemia 2017, 31 (9), 1855.Godwin, D.; Gale, P.; Walter, B. Leukemia 2017, 31 (9), 1855.

  12. [12]

      Norsworthy, K.; Chia-Wen, K.; JeeEun, L.; Jiang, L.; Christy, J.; Donna, P.; Ann, F.; Richard, P. Oncologist 2018, 23 (9), 1103.Norsworthy, K.; Chia-Wen, K.; JeeEun, L.; Jiang, L.; Christy, J.; Donna, P.; Ann, F.; Richard, P. Oncologist 2018, 23 (9), 1103.

  13. [13]

      Godwin, D.; Gale, P.; Walter, B. Leukemia 2017, 31 (9), 1855.Godwin, D.; Gale, P.; Walter, B. Leukemia 2017, 31 (9), 1855.

  14. [14]

      郭建军, 高然, 张琪, 王丽丽, 朱凌宇, 胡长亮, 史犇, 卜海之. 药物分析杂志, 2016, 36 (7), 1150.

  15. [15]

      郭立安. 高效液相色谱法纯化蛋白质理论与技术. 西安:陕西科学技术出版社, 1993.

  16. [16]

      Tosoh, B. LC GC N. AM. 2019, 37 (9), 717.Tosoh, B. LC GC N. AM. 2019, 37 (9), 717.

  17. [17]

      王文波, 武刚, 崔永菲, 于传飞, 王兰. 药物分析杂志, 2018, 38 (8), 1432.

  18. [18]

      于传飞, 王文波, 张峰, 刘春雨, 李萌, 陈伟, 郭莎, 王兰, 高凯, 王军志. 药物分析杂志, 2016, 36 (1), 35.

  19. [19]

      耿信笃, 白泉. 中国科学, 2002,32 (5), 460.

  20. [20]

      Fekete, S.; Szabolcs, F.; Jean-Luc, V.; Alain, B.; Davy, G. J. Pharm. Biomed. Anal. 2016, 130(10), 3.Fekete, S.; Szabolcs, F.; Jean-Luc, V.; Alain, B.; Davy, G. J. Pharm. Biomed. Anal. 2016, 130(10), 3.

  21. [21]

      刘洁, 连鹏. 烟台日报, 2021,12 (6), 4.

  22. [22]

      健康社. 国产首个! 荣昌生物ADC维迪西妥单抗获批.[2022-02-28]. https://www.cn-healthcare.com/articlewm/20210609/content-1229997.html

•